ALT

AU000000ALT0

Medical Equipment, Supplies & Distribution

Market Closed - Australian S.E. Other stock markets 04:32:57 28/02/2023 GMT			5-day change	1st Jan Change
0.001 ^AUD	-.--%		-.--%	-.--%

2023	Analytica Appoints Voluntary Administrators	MT
2023	Analytica CEO Resigns	MT

Analytica Limited Announces Resignation of Geoff Daly as CEO

May 12, 2023 at 12:43 am

Analytica Limited announced that Mr. Geoff Daly has resigned from his role as CEO of the Company effective May 11, 2023.

Latest news about ANALYTICA

Analytica Appoints Voluntary Administrators	13/06/23	MT
Analytica CEO Resigns	12/05/23	MT
Dr Michael Monsour Will Take on the Role of Executive Chairman of Analytica Limited	12/05/23	CI
Analytica Limited Announces Resignation of Geoff Daly as CEO	12/05/23	CI
Analytica Limited Reports Earnings Results for the Half Year Ended December 31, 2022	28/02/23	CI
Analytica Limited Reports Earnings Results for the Full Year Ended June 30, 2022	31/08/22	CI
Analytica Limited Auditor Raises 'Going Concern' Doubt	30/08/22	CI
Analytica Secures Canadian Patent for Pelvic Floor Exercise System	13/07/22	MT
Analytica Secures European, Indian Patent for Training Device	18/05/22	MT
Analytica Limited Reports Earnings Results for the Half Year Ended December 31, 2021	23/02/22	CI
Analytica Secures US Patent for PeriCoach Device	11/11/21	MT
Analytica Limited Auditor Raises 'Going Concern' Doubt	29/09/21	CI
Analytica Limited Reports Earnings Results for the Full Year Ended June 30, 2021	31/08/21	CI
Analytica : Secures US Patent for Pelvic Floor Exercise System	30/04/21	MT
Analytica Announces Expansion of Enhanced Infusion System into Middle East	27/04/21	CI
Analytica : Plans Up to $3 Million Share Placement	23/04/21	MT
Analytica : Enters Deal to Distribute Intravenous Flow Monitoring Device in Middle East	20/04/21	MT
Analytica Limited Enters into Joint Venture Agreement to Manufacture, Distribute and Market the System in China, Macau, Hong Kong and Taiwan	31/03/21	CI
Analytica Limited Reports Earnings Results for the Second Quarter Ended December 31, 2020	26/02/21	CI
Analytica Ltd Announces Publication of an Independent Clinical Trial from the University of New Mexico in the Journal of Female Pelvic Medicine & Reconstructive Surgery, the Official Journal of the American Urogynecologic Society, Demonstrating PeriCoach Non-Inferiority to In- Clinic Pelvic Floor Physical Therapy	19/11/20	CI
Analytica Limited Reports Earnings Results for the Full Year Ended June 30, 2020	31/08/20	CI
Analytica Ltd Announces Resignation of Thomas Lönngren, Non-Executive Director	18/08/20	CI
Analytica Limited Reports Earnings Results for the Half Year Ended December 31, 2019	26/02/20	CI
Analytica Ltd Announces Middle East Distribution Agreement Supplementary Disclosure	13/12/19	CI
Analytica Ltd. Reports Earnings Results for the Full Year Ended June 30, 2019	23/08/19	CI

Analytica Limited is an Australia-based product development and commercialization company that is focused on Class I and II medical device products. Its lead product is the PeriCoach System- an e-health treatment system for women who suffer stress urinary incontinence. PeriCoach includes a device, Web portal and smartphone app and the device evaluates activity in pelvic floor muscles. This information is transmitted to a smartphone app and can be loaded to a cloud database where physicians can monitor patient progress via Web portal. The Company is also the developer of the Enhanced Infusion System (EIS), a combination of technologies developed under the project names AutoStart and AutoFlush. It is also commercializing the AutoStart Burette infusion system. The EIS is a simple and inexpensive IV add-in technology to reduce nursing monitoring costs, reduce embolism risk, improve infection control and automatically restart flow after medication delivery during intravenous fluid infusion.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ANALYTICA	-.--%	3.08M
ABBOTT LABORATORIES	-5.43%	181B
MEDTRONIC PLC	+4.30%	114B
BECTON, DICKINSON AND COMPANY	-3.09%	68.29B
DEXCOM, INC.	+5.86%	52.24B
CENCORA, INC.	+8.15%	44.3B
HOYA CORPORATION	+7.52%	42.73B
METTLER-TOLEDO INTERNATIONAL, INC.	+25.54%	32.52B
TERUMO CORPORATION	+17.85%	26.02B
WEST PHARMACEUTICAL SERVICES, INC.	+1.00%	25.91B